Hierarchical Changepoint Models for Biochemical Markers Illustrated by Tracking Postradiotherapy Prostate-Specific Antigen Series in Men With Prostate Cancer
Authors:
- Carine A. BelleraCBCarine A. Bellera
- James A. HanleyJHJames A. Hanley
- Lawrence JosephLJLawrence Joseph
- Peter C. AlbertsenPAPeter C. Albertsen
- 1 April 2008
- journal article
- Published by Elsevier in Annals of Epidemiology
- Vol. 18 (4) , 270-282
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Random changepoint modelling of HIV immunologic responsesStatistics in Medicine, 2006
- Combining longitudinal studies of PSABiostatistics, 2004
- VALIDATION OF INCREASING PROSTATE SPECIFIC ANTIGEN AS A PREDICTOR OF PROSTATE CANCER DEATH AFTER TREATMENT OF LOCALIZED PROSTATE CANCER WITH SURGERY OR RADIATIONJournal of Urology, 2004
- Variation of Serum Prostate-Specific Antigen LevelsJAMA, 2003
- Predicting time to prostate cancer recurrence based on joint models for non‐linear longitudinal biomarkers and event time outcomesStatistics in Medicine, 2002
- Statistical models for longitudinal biomarkers of disease onsetStatistics in Medicine, 2000
- Taking Account of Between-Patient Variability When Modeling Decline in Alzheimer's DiseaseAmerican Journal of Epidemiology, 1999
- Bayesian Retrospective Multiple-Changepoint IdentificationJournal of the Royal Statistical Society Series C: Applied Statistics, 1994
- Hierarchical Bayes Models for the Progression of HIV Infection Using Longitudinal CD4 T-Cell NumbersJournal of the American Statistical Association, 1992
- Hierarchical Bayesian Analysis of Changepoint ProblemsJournal of the Royal Statistical Society Series C: Applied Statistics, 1992